Verve Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $115,529.57 +0.42%
Ethereum $4,155.78 -0.27%
BNB $1,143.60 -0.63%
Optimism $0.46 +0.64%
Arbitrum $0.33 -0.32%
Solana $202.44 +1.32%
Polygon $0.22 +2.77%
Cosmos $3.20 -0.26%
Avalanche $20.35 -0.57%

Bitcoin $115,529.57 +0.42%
Ethereum $4,155.78 -0.27%
BNB $1,143.60 -0.63%
Optimism $0.46 +0.64%
Arbitrum $0.33 -0.32%
Solana $202.44 +1.32%
Polygon $0.22 +2.77%
Cosmos $3.20 -0.26%
Avalanche $20.35 -0.57%

Verve Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

4

14

Verve Therapeutics is funded by 14 investors. Casdin Capital and Wellington Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Casdin Capital	Yes	Series B
Wellington Management	Yes	Series B
Biomatics Capital Partners	-	Series B
Cormorant Asset Management	-	Series B
GV	-	Series B
Janus Henderson Investors	-	Series B
Logos Capital	-	Series B
Novo Holdings	-	Series B
RA Capital Management	-	Series B
Redmile Group	-	Series B
Rock Springs Capital	-	Series B
Surveyor Capital	-	Series B
ARCH Venture Partners	-	Series A
F-Prime Capital	-	Series A